AITRICS delivers AI-powered medical software designed to support clinicians in detecting and preventing critical patient deterioration.
AITRICS has raised $23.8M in total funding. The most recent round was Series C. The last funding was announced in December 2025.
AITRICS's investors include Premier Partners, Han River Partners, HB Investment, Mirae Asset Venture Investment, Mirae Asset Capital.
AITRICS is headquartered in Seoul, South Korea.
AITRICS delivers AI-powered medical software designed to support clinicians in detecting and preventing critical patient deterioration.
AITRICS is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AITRICS — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/aitrics. Accessed August 1, 2026.
VCBacked. (2025). AITRICS — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/aitrics
{{cite web |title=AITRICS — Funding & Investors |url=https://www.vcbacked.co/company/aitrics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated